{"id":903,"date":"2003-07-01T12:03:00","date_gmt":"2003-07-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/evidence-biased-medicine"},"modified":"2003-07-01T12:03:00","modified_gmt":"2003-07-01T10:03:00","slug":"evidence-biased-medicine","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/evidence-biased-medicine","title":{"rendered":"Evidence b(i)ased medicine?"},"content":{"rendered":"<p>Eine hochinteressante Untersuchung zum Thema &#8222;Publikationsbias&#8220; und die geschickte Verf\u00e4lschung der Evidenz findet sich in einem sehr lesenswerten Heft des British Medical Journal. Die Arbeit kommt von der schwedischen Arzneimittelbeh\u00f6rde in Uppsala (Melander, H., et al.: Brit. Med. J. 2003, 326, 1171). In Schweden gibt es die Besonderheit, da\u00df pharmazeutische Firmen f\u00fcr die Zulassung einer [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eine hochinteressante Untersuchung zum Thema &#8222;Publikationsbias&#8220; und die geschickte Verf\u00e4lschung der Evidenz findet sich in einem sehr lesenswerten Heft des British Medical Journal. Die Arbeit kommt von der schwedischen Arzneimittelbeh\u00f6rde in Uppsala (Melander, H., et al.: Brit. Med. J. 2003, 326, 1171). In Schweden gibt es die Besonderheit, da\u00df pharmazeutische Firmen f\u00fcr die Zulassung einer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1451,2318,2317,2316,1409],"class_list":["post-903","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-bias","tag-evidenzbasierte-medizin","tag-publication-bias","tag-publikationsbias","tag-studien"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=903"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/903\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}